EcoDrugPlus

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 3

Ensembl ID : ENSDARG00000106018
Gene Symbol: CACNA2D3
7 Enzyme and pathways 6 Cross references
217 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 E

Ensembl ID : ENSDARG00000062346
Gene Symbol: CACNA1E
6 Enzyme and pathways 5 Cross references
216 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 Ib

Ensembl ID : ENSDARG00000096307
Gene Symbol: CACNA1IB
3 Cross references
190 Possible Orthologues:

Calcium-Sensing Receptor

Ensembl ID : ENSDARG00000013649
Gene Symbol: CASR
7 Enzyme and pathways 5 Cross references
203 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSDARG00000009020
Gene Symbol: CNR1
6 Enzyme and pathways 5 Cross references
153 Possible Orthologues:

Cannabinoid Receptor 2

Ensembl ID : ENSDARG00000039970
Gene Symbol: CNR2
6 Enzyme and pathways 5 Cross references
189 Possible Orthologues:

Carbonic Anhydrase Iv A

Ensembl ID : ENSDARG00000043589
Gene Symbol: CA4A
6 Enzyme and pathways 5 Cross references
215 Possible Orthologues:

Carbonic Anhydrase Iv B

Ensembl ID : ENSDARG00000042293
Gene Symbol: CA4B
4 Cross references
198 Possible Orthologues:

Carbonic Anhydrase Iv C

Ensembl ID : ENSDARG00000044512
Gene Symbol: CA4C
5 Cross references
201 Possible Orthologues:

Carbonic Anhydrase Vi

Ensembl ID : ENSDARG00000056499
Gene Symbol: CA6
2 Enzyme and pathways 5 Cross references
230 Possible Orthologues:

Carbonic Anhydrase Vii

Ensembl ID : ENSDARG00000045139
Gene Symbol: CA7
2 Enzyme and pathways 5 Cross references
222 Possible Orthologues:

Carbonic Anhydrase Va

Ensembl ID : ENSDARG00000101778
Gene Symbol: CA5A
2 Enzyme and pathways 5 Cross references
231 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).